clopidogrel and Peripheral Vascular Diseases

clopidogrel has been researched along with Peripheral Vascular Diseases in 77 studies

Research

Studies (77)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (9.09)18.2507
2000's54 (70.13)29.6817
2010's14 (18.18)24.3611
2020's2 (2.60)2.80

Authors

AuthorsStudies
Donia, HM; El-Askary, NA; El-Behery, AM; El-Khodary, NM; Omran, GA1
Beasley, M; Brown, TM; Cai, A; Clarkson, SA; Dillon, C; Heindl, B; Limdi, N1
Avgerinos, ED; Markel, KM1
Roditi, G; Stuart, W; Tan, AB1
Saadeh, C; Sfeir, J1
Christeas, N; Karnabatidis, D; Katsanos, K; Kitrou, P; Pastromas, G; Siablis, D; Spiliopoulos, S1
Diamantopoulos, A; Karnabatidis, D; Katsanos, K; Kitrou, P; Pastromas, G; Siablis, D; Spiliopoulos, S1
Chen, YX; Gu, YQ; Hu, HJ; Li, XQ; Liu, CW; Song, XJ; Tian, HY; Wang, WD; Zhao, JC1
Ferneini, EM; Ghantous, AE1
Bhatt, DL; Cacoub, PP; Creager, MA; Steg, PG; Topol, EJ1
Milani, RV1
Mohler, ER1
Bachoo, P; Brittenden, J; Ford, I; Nixon, GF; Wilson, AM1
Lindhoff-Last, E; Linnemann, B; Mani, H; Rechner, AR; Schwonberg, J1
Lindhoff-Last, E; Linnemann, B; Mani, H; Schwonberg, J; Toennes, SW1
Jezovnik, MK; Poredos, P1
Baumgartner, I; Becquemin, JP; Belch, JJ; Bergqvist, D; Biasi, BM; Biasi, GM; Cairols, M; Clement, D; Diehm, C; Dormandy, J; Eikelboom, B; Golledge, J; Hiatt, WR; Jawien, A; Leizorovicz, A; Lepäntalo, M; Matyas, L; Minar, E; Norgren, L; Stonebridge, P; Vermassen, F1
Alfonso, F; Baz, JA; Brugaletta, S; Capote, ML; Cárdenas, M; Casanova, J; Cascant, P; De La Torre, JM; Ferreira-González, I; García-Del Blanco, B; García-Dorado, D; González-Béjar, O; Iñiguez, A; Marsal, JR; Martí, G; Martín-Yuste, V; Permanyer-Miralda, G; Pujol, B; Ribera, A; Ruíz-Lera, M; Sabaté, M; Sánchez-Gila, J; Sanmiguel, D; Trillo, R1
Di Tommaso, L; Lillo, S; Monaco, M; Pinna, GB; Schiavone, V; Stassano, P1
Allemang, MT; Hingorani, A; Kashyap, VS; Nelson, PR; Rajani, RR1
Ciuffetti, G; Dragani, P; Lombardini, R; Mannarino, E; Pasqualini, L; Pirro, M1
Geroulakos, G; Jagroop, IA; Matsagas, MI; Mikhailidis, DP2
Dörffler-Melly, J; Mahler, F; Schmidli, J1
Geroulakos, G; Jagroop, IA; Matsagas, M; Mikhailidis, DP1
Brandner, B; Self, R1
Mikhailidis, DP; Shenton, BK; Smout, JD; Stansby, G1
Boddy, AW; Brandt, T; Buggle, F; Dukovic, DA; Grau, AJ; Hacke, W; Lichy, C1
Bravata, DM; Federman, DG; Kirsner, RS1
Aronow, WS1
Anand, SS; Tran, H1
Butz, B; Feuerbach, S; Lenhart, M; Link, J; Paetzel, C; Pfister, K; Schleicher, T; Stern, U1
Daskalopoulou, SS; Mikhailidis, DP; Stansby, G1
Cavendish, JJ; Safani, M1
Canoniero, MJ; Chirinos, JA; de Marchena, E; Ferreira, A; Garcia, S; Salerno, T1
Eriksson, P1
Brennan, DM; Cho, L; Moliterno, DJ; Mukherjee, D; Steinhubl, SR; Topol, EJ; Ziada, K1
Madi-Jebara, S; Rkeiby-Kassabian, N; Yazigi, A1
Amighi, J; Brunner, M; Exner, M; Felber, K; Funk, M; Mannhalter, C; Minar, E; Mlekusch, W; Müller, M; Sabeti, S; Schillinger, M; Ziegler, S1
Hansen, DB1
Barden, A; Claxton, A; Eikelboom, JW; Gilmore, G; Hankey, GJ; Norman, PE; Staton, J; Thom, J; Yi, Q1
Kashyap, VS; Ouriel, K; Tulsyan, N1
Kawasaki, T; Miyata, K; Takamatsu, H; Taniguchi, M; Tomura, Y; Uchida, W; Uemura, T; Yamamoto, E1
Hiatt, WR; Krantz, MJ1
Appleberg, M; Chen, Q; Lewis, DR; Morel-Kopp, MC; Ward, CM; Wong, S1
Hackam, DG1
Bagga, S; Comerota, AJ; Gaughan, J; Jalagadugula, G; Rao, AK; Vaidyula, VR; Wilhite, DB1
de Pouvourville, G; Priollet, P1
Bego, G; Carita, P; Gabriel, S; Hakimi, Z; Hankey, GJ; Spiesser, J1
Berger, PB; Bhatt, DL; Black, HR; Boden, WE; Cacoub, P; Cohen, EA; Creager, MA; Easton, JD; Fabry-Ribaudo, L; Flather, MD; Fox, KA; Hacke, W; Hamm, CW; Hankey, GJ; Hu, T; Johnston, SC; Mak, KH; Mas, JL; Montalescot, G; Pearson, TA; Steg, PG; Steinhubl, SR; Topol, EJ; Weber, MA1
Badimon, JJ; Bhatt, DL; Herbert, JM; Lüscher, TF; Steinhubl, SR1
Anand, S; Budaj, A; Cina, C; Crowell, R; Eikelboom, J; Gosselin, G; Guzman, R; Keltai, M; Liu, L; Pogue, J; Sussex, B; Xie, C; Yusuf, S1
Cavendish, JJ; Nayak, KR1
Kauert, GF; Lindhoff-Last, E; Linnemann, B; Mani, H; Schwonberg, J; Toennes, SW; Urbanek, DA1
Cave, AJ; Cox, DW; Vicaruddin, O1
Comerota, AJ; Thakur, S1
Ezekowitz, M; Lee, R; Nagarakanti, R; Sodhi, S1
Kim, S; Lipsitz, EC1
Andreozzi, GM; Arosio, E; Martini, R; Verlato, F; Visonà, A1
Violi, F1
Bahadori, B; Toplak, H; Wascher, TC1
Clagett, GP; Jackson, MR1
Fitzgerald, DJ; Quinn, MJ1
Bhatt, DL; Hacke, W; Hirsch, AT; Ringleb, PA; Topol, EJ1
Scheen, AJ1
Olin, JW1
Black, C; Paterson, KR1
Agnelli, G1
Leys, D1
Acipayam, M; Canbaz, S; Duran, E; Ege, T1
Hiatt, WR1
Geroulakos, G; Matsagas, MI; Mikhailidis, DP1

Reviews

22 review(s) available for clopidogrel and Peripheral Vascular Diseases

ArticleYear
Clopidogrel Resistance in Lower Extremity Arterial Endovascular Interventions.
    Current pharmaceutical design, 2018, Volume: 24, Issue:38

    Topics: Clopidogrel; Drug Resistance; Endovascular Procedures; Humans; Lower Extremity; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors

2018
Aspirin, Plavix, and Other Antiplatelet Medications: What the Oral and Maxillofacial Surgeon Needs to Know.
    Oral and maxillofacial surgery clinics of North America, 2016, Volume: 28, Issue:4

    Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Humans; Medication Therapy Management; Oral Surgical Procedures; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

2016
Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Jul-01, Volume: 74 Suppl 1

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Cardiovascular Diseases; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Graft Occlusion, Vascular; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency

2009
Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Jul-01, Volume: 74 Suppl 1

    Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Hemodynamics; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Thrombosis; Ticlopidine; Treatment Outcome

2009
Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:1

    Topics: Administration, Oral; Aspirin; Cardiovascular Diseases; Clopidogrel; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Treatment Outcome

2010
Epidurals and clopidogrel in peripheral vascular surgery.
    Hospital medicine (London, England : 1998), 2004, Volume: 65, Issue:1

    Topics: Analgesia, Epidural; Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Surgical Procedures

2004
Peripheral arterial disease. A systemic disease extending beyond the affected extremity.
    Geriatrics, 2004, Volume: 59, Issue:4

    Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Clopidogrel; Exercise; Geriatrics; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Smoking Cessation; Ticlopidine

2004
Antiplatelet therapy in peripheral arterial disease.
    Current drug targets. Cardiovascular & haematological disorders, 2004, Volume: 4, Issue:3

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome

2004
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    JAMA, 2004, Oct-20, Volume: 292, Issue:15

    Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Ticlopidine

2004
Emerging drugs in peripheral arterial disease.
    Expert opinion on emerging drugs, 2006, Volume: 11, Issue:1

    Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Arteries; Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Intermittent Claudication; Ischemic Attack, Transient; Myocardial Infarction; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; Tissue Plasminogen Activator; Vasodilator Agents

2006
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
    Vascular medicine (London, England), 2006, Volume: 11, Issue:1

    Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Intermittent Claudication; Lower Extremity; Meta-Analysis as Topic; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ticlopidine

2006
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.
    Vascular medicine (London, England), 2007, Volume: 12, Issue:2

    Topics: Angina, Unstable; Aspirin; Atherosclerosis; Biomarkers; Blood Platelets; Clopidogrel; Humans; Inflammation; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Ticlopidine

2007
Risk reduction with clopidogrel in the management of peripheral arterial disease.
    Vascular health and risk management, 2007, Volume: 3, Issue:3

    Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine

2007
Antiplatelet therapy for vascular interventions.
    Perspectives in vascular surgery and endovascular therapy, 2008, Volume: 20, Issue:1

    Topics: Angioplasty, Balloon; Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Humans; Inguinal Canal; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Vascular Surgical Procedures

2008
Chronic antithrombotic therapy in post-myocardial infarction patients.
    Cardiology clinics, 2008, Volume: 26, Issue:2

    Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombolytic Therapy; Thrombosis; Ticlopidine; Vitamin K; Warfarin

2008
Antithrombotic therapy in peripheral arterial occlusive disease.
    Chest, 1998, Volume: 114, Issue:5 Suppl

    Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Endarterectomy, Carotid; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin

1998
Ticlopidine and clopidogrel.
    Circulation, 1999, Oct-12, Volume: 100, Issue:15

    Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bone Marrow Diseases; Carbamazepine; Cardiovascular Diseases; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Interactions; Hemorrhage; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Phenytoin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Safety; Stents; Theophylline; Thrombolytic Therapy; Ticlopidine

1999
New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?
    Adverse drug reactions and toxicological reviews, 2001, Volume: 20, Issue:4

    Topics: Aspirin; Bone Marrow; Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine

2001
Rationale for the use of platelet aggregation inhibitors in PAD patients.
    Vascular medicine (London, England), 2001, Volume: 6, Issue:3 Suppl

    Topics: Aspirin; Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome

2001
Atherothrombosis--the neurologist's point of view.
    Vascular medicine (London, England), 2001, Volume: 6, Issue:3 Suppl

    Topics: Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Stroke; Thrombosis; Ticlopidine; Time Factors

2001
Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy.
    Journal of internal medicine, 2002, Volume: 251, Issue:3

    Topics: Algorithms; Arteriosclerosis; Aspirin; Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine

2002
The role of platelets in peripheral arterial disease: therapeutic implications.
    Annals of vascular surgery, 2002, Volume: 16, Issue:2

    Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine

2002

Trials

21 trial(s) available for clopidogrel and Peripheral Vascular Diseases

ArticleYear
Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery.
    Journal of vascular surgery, 2013, Volume: 58, Issue:6

    Topics: Aged; Clopidogrel; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Preoperative Care; Prognosis; Prospective Studies; Ticlopidine; Vascular Surgical Procedures; Withholding Treatment

2013
Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results.
    Chinese medical journal, 2015, Jun-20, Volume: 128, Issue:12

    Topics: Aged; Arterial Occlusive Diseases; Clopidogrel; Female; Fibrinolytic Agents; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Serotonin Antagonists; Succinates; Ticlopidine

2015
Patients with peripheral arterial disease in the CHARISMA trial.
    European heart journal, 2009, Volume: 30, Issue:2

    Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

2009
Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
    Journal of vascular surgery, 2009, Volume: 50, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Aspirin; Biomarkers; Blotting, Western; Cell Proliferation; Cells, Cultured; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; E-Selectin; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Graft Occlusion, Vascular; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Mitogen-Activated Protein Kinase 3; Multivariate Analysis; Muscle, Smooth, Vascular; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Probability; Radiography; Reference Values; Statistics, Nonparametric; Ticlopidine

2009
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y.
    Annals of hematology, 2010, Volume: 89, Issue:6

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Catheterization, Peripheral; Clopidogrel; Diagnostic Techniques, Cardiovascular; Female; Fibrinolytic Agents; Hemostasis; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Prognosis; Reagent Kits, Diagnostic; Ticlopidine; Treatment Failure

2010
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.
    Journal of vascular surgery, 2010, Volume: 52, Issue:4

    Topics: Aged; Amputation, Surgical; Aspirin; Australia; Blood Vessel Prosthesis Implantation; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Kaplan-Meier Estimate; Lower Extremity; Male; Middle Aged; Peripheral Vascular Diseases; Placebo Effect; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Reoperation; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency; Veins

2010
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
    Circulation, 2010, Sep-07, Volume: 122, Issue:10

    Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Patient Readmission; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Self Medication; Thrombosis; Ticlopidine

2010
Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.
    Journal of vascular surgery, 2012, Volume: 56, Issue:1

    Topics: Administration, Oral; Aged; Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Comorbidity; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Logistic Models; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Popliteal Artery; Proportional Hazards Models; Prospective Studies; Ticlopidine; Treatment Outcome; Vascular Patency; Warfarin

2012
A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease.
    Journal of clinical pathology, 2002, Volume: 55, Issue:12

    Topics: Adult; Arterial Occlusive Diseases; Blood Platelets; Blood Viscosity; Cell Adhesion; Clopidogrel; Double-Blind Method; Exercise Test; Humans; Leukocytes; Male; Microcirculation; Middle Aged; Oxygen; Partial Pressure; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine

2002
The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2003, Volume: 9, Issue:2

    Topics: Aged; Aspirin; Blood Platelets; Cell Size; Clopidogrel; Drug Resistance; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Serotonin; Ticlopidine

2003
Combination antiplatelet therapy in patients with peripheral vascular bypass grafts.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2004, Volume: 10, Issue:1

    Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Drug Therapy, Combination; Female; Flow Cytometry; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine

2004
Leukocyte count as an independent predictor of recurrent ischemic events.
    Stroke, 2004, Volume: 35, Issue:5

    Topics: Aspirin; Biomarkers; Brain Ischemia; Cause of Death; Clopidogrel; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Risk Factors; Stroke; Ticlopidine

2004
The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Platelets, 2004, Volume: 15, Issue:2

    Topics: Adenosine Diphosphate; Aged; Arteriosclerosis; Aspirin; Blood Platelets; Cell Shape; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; P-Selectin; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Serotonin; Ticlopidine

2004
Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:1

    Topics: Aged; Cerebrovascular Disorders; Clopidogrel; Epidemiologic Methods; Female; Humans; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome

2006
Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:12

    Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Biomarkers; Clopidogrel; Collagen; Cross-Over Studies; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine

2005
Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:6

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine

2006
Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Thrombosis and haemostasis, 2006, Volume: 96, Issue:6

    Topics: Aged; Aged, 80 and over; Antithrombin III; Aspirin; Blood Platelets; C-Reactive Protein; CD40 Ligand; Cell Membrane; Cilostazol; Clopidogrel; Down-Regulation; Drug Therapy, Combination; Factor VIIa; Humans; Middle Aged; P-Selectin; Peptide Fragments; Peptide Hydrolases; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Tetrazoles; Thromboplastin; Ticlopidine

2006
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Journal of the American College of Cardiology, 2007, May-15, Volume: 49, Issue:19

    Topics: Aged; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome

2007
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    The New England journal of medicine, 2007, Jul-19, Volume: 357, Issue:3

    Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin

2007
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
    Lancet (London, England), 1996, Nov-16, Volume: 348, Issue:9038

    Topics: Adult; Arteriosclerosis; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Myocardial Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome

1996
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators.
    American heart journal, 2000, Volume: 140, Issue:1

    Topics: Aspirin; Brain Ischemia; Cause of Death; Clopidogrel; Confidence Intervals; Double-Blind Method; Female; Hemorrhage; Hospitalization; Humans; Incidence; Ischemia; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Probability; Prognosis; Proportional Hazards Models; Risk Assessment; Secondary Prevention; Survival Analysis; Ticlopidine

2000

Other Studies

34 other study(ies) available for clopidogrel and Peripheral Vascular Diseases

ArticleYear
The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:19

    Topics: Aged; Alleles; Blood Platelets; Clopidogrel; Cross-Sectional Studies; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Drug Resistance; Egypt; Female; Genotype; Humans; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide

2021
Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome.
    The American journal of cardiology, 2021, 06-01, Volume: 148

    Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Case-Control Studies; Clopidogrel; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Heart Failure; Hemorrhage; Hospitalization; Humans; Ischemic Attack, Transient; Ischemic Stroke; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; ST Elevation Myocardial Infarction; Stroke Volume; Ticagrelor; Treatment Outcome

2021
Peroneal artery entrapment syndrome (PRAES): a rare cause of ischaemic toes.
    BMJ case reports, 2019, Jan-28, Volume: 12, Issue:1

    Topics: Aged; Atherosclerosis; Clopidogrel; Constriction, Pathologic; Diagnosis, Differential; Embolism; Humans; Leg; Magnetic Resonance Angiography; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Syndrome; Tibial Arteries; Toes

2019
Prevalence of nonresponsiveness to aspirin in patients with symptomatic peripheral arterial disease using true point of care testing.
    Cardiovascular and interventional radiology, 2014, Volume: 37, Issue:3

    Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Female; Humans; Male; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Risk Factors; Ticlopidine

2014
Initial experience with ticagrelor in patients with critical limb ischemia and high on-clopidogrel platelet reactivity undergoing complex peripheral endovascular procedures.
    Cardiovascular and interventional radiology, 2014, Volume: 37, Issue:6

    Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Endovascular Procedures; Female; Follow-Up Studies; Humans; Leg; Limb Salvage; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Survival Rate; Ticagrelor; Ticlopidine; Treatment Outcome

2014
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire international, 2009, Volume: 18, Issue:104

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk; Stents; Stroke; Thromboembolism; Thrombosis; Ticlopidine; Warfarin

2009
Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive disease.
    Atherosclerosis, 2010, Volume: 209, Issue:2

    Topics: Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Female; Humans; Male; Middle Aged; Patient Compliance; Peripheral Vascular Diseases; Platelet Aggregation; Ticlopidine

2010
Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
    Annals of vascular surgery, 2013, Volume: 27, Issue:1

    Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug Utilization Review; Endovascular Procedures; Guideline Adherence; Health Care Surveys; Humans; Lower Extremity; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Stents; Surveys and Questionnaires; Ticlopidine; Time Factors; Warfarin

2013
Is aspirin still the antiplatelet drug of choice for patients with peripheral arterial disease?
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2003, Volume: 25, Issue:3

    Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

2003
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1

    Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Confidence Intervals; Dipyridamole; Drug Therapy, Combination; Embolectomy; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Iloprost; Intermittent Claudication; Leg; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombectomy; Ticlopidine; Time Factors; Vitamin K

2003
[Even when walking yet does not cause any pain, peripheral arterial occlusive disease costs life years].
    MMW Fortschritte der Medizin, 2003, Apr-10, Volume: 145, Issue:15

    Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Clopidogrel; Diabetes Complications; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Walking

2003
Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results.
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Angiography; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Carbon; Clopidogrel; Constriction, Pathologic; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Iliac Artery; Injections, Intravenous; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency

2004
Clopidogrel and vascular disease prevention.
    Current medical research and opinion, 2004, Volume: 20, Issue:11

    Topics: Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

2004
Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Current medical research and opinion, 2004, Volume: 20, Issue:11

    Topics: Aged; Aged, 80 and over; Arteriosclerosis; Clopidogrel; Female; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

2004
Development of a score to predict the need for coronary artery bypass graft surgery in patients with non-ST segment elevation acute coronary syndromes.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:6

    Topics: Aged; Angina, Unstable; Clopidogrel; Coronary Artery Bypass; Heart Failure; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Retrospective Studies; ROC Curve; Ticlopidine

2004
Creative cost-effectiveness analysis of CAPRIE data- dust in our eyes.
    The American journal of medicine, 2005, Volume: 118, Issue:2

    Topics: Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Drug Costs; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Stroke; Ticlopidine

2005
[Antiplatelet agents and regional anaesthesia: experience in 130 patients].
    Annales francaises d'anesthesie et de reanimation, 2005, Volume: 24, Issue:5

    Topics: Aged; Aspirin; Autonomic Nerve Block; Blood Loss, Surgical; Blood Vessel Prosthesis Implantation; Clopidogrel; Endarterectomy, Carotid; Hematoma; Hemorrhage; Humans; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Prospective Studies; Punctures; Risk; Ticlopidine

2005
Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease.
    Stroke, 2005, Volume: 36, Issue:7

    Topics: Aged; Alleles; Aspirin; Brain Ischemia; Cerebrovascular Circulation; Clopidogrel; Cohort Studies; Exons; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Ischemia; Membrane Proteins; Middle Aged; Mutation; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Polymorphism, Genetic; Prevalence; Proportional Hazards Models; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine; Time Factors; Treatment Outcome

2005
The (variable) definition of benefit in the case of clopidogrel vs aspirin.
    Archives of internal medicine, 2005, Jun-13, Volume: 165, Issue:11

    Topics: Aspirin; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome; Vascular Diseases

2005
Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats.
    European journal of pharmacology, 2006, Apr-24, Volume: 536, Issue:1-2

    Topics: Animals; Aorta; Blood Flow Velocity; Blood Pressure; Clopidogrel; Dermis; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Rate; Hindlimb; In Vitro Techniques; Lauric Acids; Male; Peptides, Cyclic; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Ticlopidine; Vasodilation; Vasodilator Agents

2006
Medical management of peripheral arterial disease.
    JAMA, 2006, Jul-05, Volume: 296, Issue:1

    Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Humans; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors; Ticlopidine

2006
[Impact of the choice of an antiplatelet therapy for peripheral arterial disease: cost-effectiveness ratio and health economics assessment].
    Journal des maladies vasculaires, 2007, Volume: 32, Issue:1

    Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

2007
Rate, degree, and predictors of recovery from disability following ischemic stroke.
    Neurology, 2007, May-08, Volume: 68, Issue:19

    Topics: Aged; Brain Ischemia; Causality; Clopidogrel; Cohort Studies; Diabetes Complications; Disability Evaluation; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prognosis; Prospective Studies; Recovery of Function; Regression Analysis; Stroke; Ticlopidine; Time Factors; Treatment Outcome

2007
Determination of clopidogrel main metabolite in plasma: a useful tool for monitoring therapy?
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:1

    Topics: Aged; Chromatography, High Pressure Liquid; Clopidogrel; Female; Humans; Male; Mass Spectrometry; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

2008
Loss of taste with clopidogrel.
    Canadian family physician Medecin de famille canadien, 2008, Volume: 54, Issue:2

    Topics: Aged; Ageusia; Clopidogrel; Humans; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Weight Loss

2008
Antithrombotic therapy in peripheral arterial disease.
    Cardiology clinics, 2008, Volume: 26, Issue:2

    Topics: Anticoagulants; Aspirin; Atherosclerosis; Cilostazol; Clopidogrel; Comorbidity; Diabetic Angiopathies; Humans; Hypertension; Intermittent Claudication; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Tetrazoles; Thrombolytic Therapy; Ticlopidine

2008
Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition - Abano Terme (Italy) - May 2005 2nd revision - Portroz (Slovenia) September 2007.
    International angiology : a journal of the International Union of Angiology, 2008, Volume: 27, Issue:2

    Topics: Aspirin; Carotid Stenosis; Clopidogrel; Disease Progression; Exercise Test; Humans; Intermittent Claudication; Ischemia; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Ultrasonography, Doppler, Color

2008
CAPRIE trial.
    Lancet (London, England), 1997, Feb-01, Volume: 349, Issue:9048

    Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome

1997
CAPRIE trial.
    Lancet (London, England), 1997, Feb-01, Volume: 349, Issue:9048

    Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Ticlopidine; Treatment Outcome

1997
[Myocardial infarct, stroke and vascular events reduced by a third].
    Zeitschrift fur Kardiologie, 1997, Volume: 86, Issue:11 Suppl M

    Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

1997
[Prevention in the 21st century. Athero-thrombosis and ischemic events].
    Zeitschrift fur Kardiologie, 1998, Volume: 87, Issue:11 Suppl A

    Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Female; Forecasting; Humans; Male; Myocardial Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine

1998
[Pharmacy clinics. Medication of the month. Clopidogrel (Plavix)].
    Revue medicale de Liege, 2001, Volume: 56, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Myocardial Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine

2001
Antiplatelet therapy: a vascular medicine perspective.
    Managed care (Langhorne, Pa.), 2000, Volume: 9, Issue:10 Suppl

    Topics: Aspirin; Clopidogrel; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; United States

2000
Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting.
    Platelets, 2001, Volume: 12, Issue:8

    Topics: Arteries; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Graft Occlusion, Vascular; Humans; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Patency

2001